Bioderma Atoderm Intensive Baume Ultra Soothing Balm 45ml

Rebuilds weakened skin barriers and calms persistent dryness using a clinically structured blend of Lipigenium complex biolipids and palmitoylethanolamide (PEA). This 45ml intensive formula moves beyond temporary surface occlusion by delivering active compounds that stimulate your native epidermal cells to generate essential proteins and intercellular cement.

The Lipigenium complex contains bio-molecules identical to those naturally occurring in healthy skin tissue. Upon contact, they signal keratinocytes to accelerate lipid and protein synthesis, effectively patching micro-fissures triggered by extreme dehydration or atopic dermatitis. Simultaneously, PEA functions as an anti-pruritic agent that modulates local inflammatory pathways responsible for relentless scratching, delivering tangible comfort without introducing corticosteroids.

Engineered specifically for very dry and compromised skin, the balm utilizes a non-sticky finish that glides smoothly across knuckles, calves, hands, and reactive facial patches. Its Skin Barrier Therapy framework further restricts bacterial adhesion on damaged surfaces, lowering infection susceptibility during acute flare periods while preserving a weightless sensory feel.

Biological mechanisms and structural advantages

• Native barrier reconstruction: Lipigenium complex redirects cellular lipid production to seal moisture loss at the source rather than masking it
• Pruritus modulation: Palmitoylethanolamide (PEA) attenuates itch signaling for sustained relief across waking and sleeping hours
• Pathogen resistance layer: Establishes a cohesive shield that reduces microorganism attachment on fractured stratum corneum
• Controlled dosing format: Sealed 45ml tube ensures precise application volume and hygienic storage for concentrated problem spots

Dispense a uniform layer directly onto affected regions following gentle cleansing. Formulated to complement existing topical regimens, this concentrated balm merges with prescribed eczema therapies without altering their pharmacological uptake efficiency.